Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Filings indexed 402 across all filing types
Latest filing 2024-08-01 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.